EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease

Yelena Drexler, Alessia Fornoni

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci174015 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Yelena Drexler und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus, Type 2HumansAdenineBiomarkersMetabolomicsKidney

Substanzen

AdenineBiomarkers

Zitieren

APA

Drexler, Y., & Fornoni, A. (2023). Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci174015

Vancouver

Drexler Y, Fornoni A. Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease. Journal of Clinical Investigation. 2023. doi:10.1172/jci174015

BibTeX
@article{Drexler2023,
  author = {Drexler, Yelena and Fornoni, Alessia},
  title = {Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci174015}
}
Kostenlos starten →